Patient#	Sample#	ACP1:(ACP1, protein),	CBL:(CBL, protein),	EFNA1:(EFNA1, protein),	EPHA2:(EPHA2, protein),	GRB2:(GRB2, protein),	INPPL1:(INPPL1, protein),	SRC:(SRC, protein),	TIAM1:(TIAM1, protein),	VAV2-VAV3:(VAV2-VAV3, protein),	p52 SHC:(p52 SHC, protein),	Ephrin A1/EPHA2:(EFNA1, active),(EPHA2, active),(cell-cell signaling, active),	Ephrin A1/EPHA2/LMW-PTP:(ACP1, active),(Ephrin A1/EPHA2, active),	Ephrin A1/EPHA2/PI3K:(Ephrin A1/EPHA2, active),(PI3K, active),	Ephrin A1/EPHA2/Src:(Ephrin A1/EPHA2, active),(SRC, active),	Ephrin A1/EPHA2/Tiam1:(Ephrin A1/EPHA2, active),(TIAM1, active),	Ephrin A1/EPHA2/VAV2-VAV3:(Ephrin A1/EPHA2, active),(VAV2-VAV3, active),	Ephrin A1/EPHA2/p52 SHC:(Ephrin A1/EPHA2, active),(p52 SHC, active),	FAK:(Ephrin A1/EPHA2, active),(FAK, protein),(protein tyrosine phosphatase activity, active),	p130 Cas:(Ephrin A1/EPHA2, active),(p130 Cas, protein),	proteasomal ubiquitin-dependent protein catabolic process:(CBL, active),(Ephrin A1/EPHA2, active),	Ephrin A1/EPHA2/p52 SHC/GRB2:(Ephrin A1/EPHA2/p52 SHC, active),(GRB2, active),	PI-3-4-5-P3:(Ephrin A1/EPHA2/PI3K, active),(PI-4-5-P2, active),	angiogenesis:(Ephrin A1/EPHA2/VAV2-VAV3, active),	p190RhoGAP:(Ephrin A1/EPHA2/LMW-PTP, active),(p190RhoGAP, protein),	MAPKKK cascade:(Ephrin A1/EPHA2/p52 SHC/GRB2, active),	PI-3-4-P2:(INPPL1, active),(PI-3-4-5-P3, active),	cell adhesion mediated by integrin:(FAK, active),	PAK1	endocytosis:(Ephrin A1/EPHA2, active),(PAK1, active),	endothelial cell migration:(PAK1, active),	neuron projection morphogenesis:(PAK1, active),	GTP	GDP	RAC1/GDP:(Ephrin A1/EPHA2, active),(GDP, active),(PAK1, active),(S1P, active),	RhoA/GDP	RhoA/GTP:(Ephrin A1/EPHA2, active),(GTP, active),(RhoA/GDP, active),	cell-cell adhesion:(Ephrin A1/EPHA2/Src, active),(RhoA/GTP, active),	substrate adhesion-dependent cell spreading:(FAK, active),(PAK1, active),(RhoA/GTP, active),(p130 Cas, active),	
